4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with caffeine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (63.16) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Chatterjee, SK; Kim, U | 1 |
| Glass, WF; Moore, JB | 1 |
| Lehnert, S | 1 |
| Collier, HO; Francis, DL; Roy, AC | 1 |
| Beatty, CH; Bocek, RM | 1 |
| Furihata, C; Matsushima, T; Sugimura, T; Terai, M | 1 |
| Dodd, G; Menevse, A; Poynder, TM | 1 |
| Lederis, K; Mathison, R | 1 |
| Dohi, T; Kitayama, S; Morita, K; Tsujimoto, A | 1 |
| Collier, HO; Cuthbert, NJ; Francis, DL | 1 |
| Daniel, JW; Oleinick, NL | 1 |
| Fochtmann, L; Francis, A | 1 |
| Chang, YH; Chern, Y; Ching, YH; Conti, M; Lai, HL; Lee, YC | 1 |
| Howell, LL; Landrum, AM | 1 |
| Coyle, TS; Kaplan, GB | 1 |
| Bamburg, JR; Bedford, JS; Bernstein, BW; Jha, MN | 1 |
| Chai, Y; Lin, YF; Mao, X | 1 |
19 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and caffeine
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Biochemical properties of cyclic nucleotide phosphodiesterase in metastasizing and nonmetastasizing rat mammary carcinomas.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Caffeine; Calcium; Cobalt; Cyclic AMP; Cyclic GMP; Depression, Chemical; Edetic Acid; Egtazic Acid; Hydrogen-Ion Concentration; Magnesium; Manganese; Neoplasm Metastasis; Nickel; Purine Nucleotides; Pyrimidine Nucleotides; Rats; Theophylline; Zinc | 1976 |
Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Aminophylline; Caffeine; Etazolate; Humans; In Vitro Techniques; Kinetics; Lung; Nucleosides; Nucleotides, Cyclic | 1979 |
Radioprotection of mouse intestine by inhibitors of cyclic AMP phosphodiesterase.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Caffeine; Cell Survival; Jejunum; Male; Mice; Radiation-Protective Agents; Reserpine; Theophylline | 1979 |
Morphone abstinence and quasi-abstinence effects after phosphodiesterase inhibitors and naloxone.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Caffeine; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Male; Morphine; Naloxone; Phosphodiesterase Inhibitors; Prostaglandins; Rats; Structure-Activity Relationship; Substance Withdrawal Syndrome; Theophylline; Time Factors; Xanthines | 1975 |
Cyclic AMP phosphodiesterase activity in fetal and adult muscle of the rhesus monkey.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Caffeine; Female; Kinetics; Macaca; Macaca mulatta; Male; Muscles; Phosphoric Diester Hydrolases; Pregnancy; Theophylline; Xanthines | 1976 |
Partial purification of adenosine 3',5'-cyclic monophosphate phosphodiesterases from rat pancreas in the presence of excess protease inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Caffeine; Cyclic GMP; Cyclic IMP; Isoenzymes; Kinetics; Male; Pancreas; Phosphoric Diester Hydrolases; Protease Inhibitors; Rats; Theophylline | 1976 |
Evidence for the specific involvement of cyclic AMP in the olfactory transduction mechanism.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Anura; Caffeine; Cyclic AMP; Electrophysiology; Etazolate; Odorants; Olfactory Mucosa; Phosphodiesterase Inhibitors; Rana temporaria; Smell; Theophylline | 1977 |
Inhibitory effects of cyclic AMP on vasopressin release from the rat neural lobe in vitro.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Bucladesine; Caffeine; Cyclic AMP; Dose-Response Relationship, Drug; Etazolate; In Vitro Techniques; Male; Papaverine; Pituitary Gland; Rats; Vasopressins; Xanthines | 1977 |
Forskolin enhancement of acetylcholine-evoked cyclic AMP formation and catecholamine release in perfused dog adrenals.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Acetylcholine; Adrenal Glands; Animals; Caffeine; Calcium; Catecholamines; Colforsin; Cyclic AMP; Dogs; Female; In Vitro Techniques; Male; Potassium | 1986 |
Character and meaning of quasi-morphine withdrawal phenomena elicited by methylxanthines.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Caffeine; Humans; Hypoxanthines; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Phosphodiesterase Inhibitors; Pyrimidines; Rats; Substance Withdrawal Syndrome; Theobromine; Theophylline; Triazoles; Xanthines | 1981 |
Cyclic nucleotide responses and radiation-induced mitotic delay in Physarum polycephalum.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Caffeine; Cobalt Radioisotopes; Cyclic AMP; Cyclic GMP; Gamma Rays; Mitosis; Phosphodiesterase Inhibitors; Physarum; Theophylline; Time Factors | 1984 |
Reduced proconvulsant activity of caffeine in rats after a series of electroconvulsive seizures.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Caffeine; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Electroshock; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Seizures; Theobromine; Time Factors | 1995 |
Activation of phosphodiesterase IV during desensitization of the A2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Adrenal Gland Neoplasms; Animals; Blotting, Western; Caffeine; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; Enzyme Activation; Enzyme Inhibitors; Isoquinolines; Kinetics; PC12 Cells; Phenethylamines; Pheochromocytoma; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Polymerase Chain Reaction; Purinergic P1 Receptor Agonists; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Recombinant Proteins; Sulfonamides | 1997 |
Effects of chronic caffeine administration on respiration and schedule-controlled behavior in rhesus monkeys.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Caffeine; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Tolerance; Female; Macaca mulatta; Male; Pyrrolidinones; Respiration; Rolipram; Theophylline | 1997 |
Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine Kinase; Animals; Body Weight; Caffeine; Deoxyadenosines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; Mice; Morphine; Receptors, Purinergic P1; Substance Withdrawal Syndrome | 1998 |
Caffeine eliminates gamma-ray-induced G2-phase delay in human tumor cells but not in normal cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Breast Neoplasms; Caffeine; Calcium Channel Blockers; Calcium Signaling; Carcinoma; Chickens; Demecolcine; Drug Resistance; Female; Fibroblasts; G2 Phase; Gamma Rays; HeLa Cells; Humans; Mitosis; Neoplastic Stem Cells; Neurons; Ovarian Neoplasms; Phosphodiesterase Inhibitors; Quinazolines; Radiation Tolerance; Ryanodine; Ryanodine Receptor Calcium Release Channel; Thapsigargin; Tumor Cells, Cultured | 2002 |
Dual regulation of the ATP-sensitive potassium channel by caffeine.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine Triphosphate; Animals; Caffeine; Carbazoles; Cell Line; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Indoles; Insulin; Insulin Secretion; Ion Channel Gating; Islets of Langerhans; Isoquinolines; Muscle, Smooth; Pancreas; Potassium Channels; Protein Isoforms; Purinones; Rats; Sulfonamides | 2007 |